Evidence map›Paper›PMID 41399449›Full record

ArticleJournal of oral biology and craniofacial research

A novel histopathological subclassification of oral submucous fibrosis based on epithelial keratinization: A proof-of-concept pilot observation.

Gargi S Sarode, Sachin C Sarode

Abstract read
In one paragraph

Article in Journal of oral biology and craniofacial research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gargi S SarodeDepartment of Oral Pathology and Microbiology, Dr. D.Y. Patil Dental College and Hospital, Dr. D.Y. Patil Vidyapeeth, Sant-Tukaram Nagar, Pimpri, Pune, 411018, MH, India.
Sachin C SarodeDepartment of Oral Pathology and Microbiology, Dr. D.Y. Patil Dental College and Hospital, Dr. D.Y. Patil Vidyapeeth, Sant-Tukaram Nagar, Pimpri, Pune, 411018, MH, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral submucous fibrosis (OSMF) is a chronic, progressive oral potentially malignant disorder strongly associated with areca nut consumption. Despite extensive research, a reliable and clinically applicable biomarker for predicting malignant transformation remains unavailable. The present pilot investigation introduces a novel concept by classifying OSMF into two histopathological variants-hyperkeratinized and non-hyperkeratinized-based on epithelial keratinization patterns, a distinction not previously described in the literature. Archival biopsy samples of 51 histologically confirmed OSMF cases from the buccal mucosa were analyzed for keratinization type and epithelial dysplasia. Additionally, 37 cases of oral squamous cell carcinoma arising in the background of OSMF (OSCC-OSMF) were examined for keratinization at surgical margins. Among OSMF cases, 19.6 % exhibited hyperkeratinization, all showing high-risk epithelial dysplasia, whereas 90.2 % of normally keratinized cases demonstrated low-risk dysplasia. In OSCC-OSMF specimens, 60 % of surgical margins revealed hyperkeratinization. These findings suggest that epithelial hyperkeratinization may represent an early histological alteration associated with malignant transformation rather than a protective epithelial response. Although limited by small sample size, this study provides proof-of-concept for a novel histopathological subclassification of OSMF, warranting validation through larger, multicentre longitudinal and molecular correlation studies.

Indexed as

Histopathological biomarkerHyperkeratinizationMalignant transformationOral submucous fibrosis

Identifiers

PMID41399449
PMCPMC12702200

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.